Table 10. .
Identified FANCD2 Mutations and Their Effects
Mutationa |
Consequencea |
||
Location and Patient No(s). | Genomic DNA | RNA | Protein |
Exon 2: | |||
32 | c.2T→C | r.2T→C | Failure of normal translation initiation |
Intron 3: | |||
28 and 29 | c.206-2A→T (IVS3-2 A→T) | r.206_273del68 (exon 4 skipping) | p.A69DfsX7 |
Intron 4: | |||
6, 12, and 30 | c.274-57_-56insinvAluYb8nt36_319 +dup c.274-69_−57b | r.274_377del104 (exon 5 skipping) | p.I92YfsX7 |
Exon 5: | |||
26 and 27 | c.376A→G | r.376A→G+r.377_378ins13 (aberrant splicing) | p.S126RfsX12 |
Exon 9: | |||
19 | c.692T→G | r.692T→G | p.L231R |
Intron 9: | |||
1 | c.696-121C→G (IVS9-12 1C→G) | r.695+1619_696-126ins34 (exonization) | p.S232insQNNFX |
18 | c.696-2A→T (IVS9-2 A→T) | r.696_783del88 (exon 10 skipping) | p.S232RfsX6 |
Exon 10: | |||
23 and 24 | c.757C→T | r.757C→T | p.R253X |
31 and 33 | c.782A→T | r.696_783del88 (exon 10 skipping) | p.S232RfsX6 |
Exon 11: | |||
9 | c.810_812delGTC | r.810_812delGTC | p.S271del |
Exon 12: | |||
7 | c.904C→T | r.904C→T | p.R302W |
Intron 12: | |||
8 | c.990-1G→A (IVS12-1 G→A) | r.990del8 (aberrant splicing) | p.S330RfsX16 |
Exon 13: | |||
7 | c.1092G→A | r.1092G→A | p.W364X |
Intron 14: | |||
33 | g.13377_17458dup4082 (duplication, including exons 11–14) | r.784_1134dup (duplication of 351 nt in-frame) | p.262_378dup (duplication of 117 aa) |
Exon 16: | |||
18 | c.1321_1322delAG | r.1135_1545del411 (exon 15–17 skipping) | p.V379_K515del |
23 and 24 | c.1367T→G | r.1367T→G | p.L456R |
31 | c.1370T→C | r.1370T→C | p.L457P |
Exon 17: | |||
28, 29 | g.22875_23333del459 (c.1414-71_c.1545+256del459) | r.1414_1545del132 | p.E472_K515del |
Intron 21: | |||
3, 4, 5, 9, 10, 13, and 25 | c.1948-16T→G (IVS21-16 T→G) | r.1948_2021del74 (exon 22 skipping) | p.E650X |
2, 8, 14, 15, and 20 | c.1948-6C→A (IVS21-6 C→A) | r.1948_2021del74 (exon 22 skipping) | p.E650X |
Exon 26: | |||
21 | c.2404C→T | r.2404C→T | p.Q802X |
16, 17, 19, 21, 22, and 30 | c.2444G→A | r.2444G→A | p.R815Q |
Exon 28: | |||
20 | c.2660delA | r.2660delA | p.E888RfsX16 |
Intron 28: | |||
10 and 22 | c.2715+1G→A (IVS28+1G→A) | r.2715_2716ins27 (aberrant splicing) | p.E906LfsX4 |
Exon 29: | |||
14 and 15 | c. 2775_2776CC→TT | r. 2775_2776CC→TT | p.R926X |
11 | c.2835dupC | r.2835dupC | p.D947RfsX3 |
Exon 34: | |||
12 | c.3453_3456delCAAA | r.3453_3456delCAAA | p.N1151KfsX46 |
Exon 36: | |||
2 | c.3599delT | r.3599delT | p.I1200KfsX12 |
Exon 37: | |||
32 | c.3706C→A | r.3684_3707del24 (aberrant splicing) | p.R1228S_F1235del |
11 | c.3707G→A | r.3684_3727del44 (aberrant splicing) | p.H1229EfsX7 |
Exon 38: | |||
6, 26, and 27 | c.3803G→A | r.3803G→A | p.W1268X |
Nomenclature is according to the Human Genome Variation Society.
This Alu was identical to the evolutionary young subfamily Yb8.43,44 It was lacking its annotated nucleotides 1–35, had integrated in reverse orientation (with its poly-A tail toward the 5′ end of FANCD2), and had duplicated the 13-nt sequence c.274–69 to c.274–57 of FANCD2 IVS4, such that this duplicated sequence flanked the Alu repeat on both sides. Altogether, the insertion length was 298 bp.